Breaking News Instant updates and real-time market news.

HFC

HollyFrontier

$27.09 /

-0.94 (-3.35%)

07:15
07/08/20
07/08
07:15
07/08/20
07:15

HollyFrontier downgraded to Underweight at Morgan Stanley

As previously reported, Morgan Stanley analyst Benny Wong downgraded HollyFrontier to Underweight from Equal Weight with a price target of $32, down from $40, as he also lowered his U.S. Refining & Marketing industry view to In-Line. His view on the group is driven by what he sees as fair valuations in the space, a potential drag in their margin recovery, and negative earnings revision risk in the second half and 2021. For HollyFrontier in particular, Wong cites narrower inland crude differentials reducing margin capture and limiting earnings upside and the fact that the company is entering a cycle of higher capex spend in its renewable diesel business.

  • 06

    Aug

HFC HollyFrontier
$27.09 /

-0.94 (-3.35%)

07/08/20 Morgan Stanley
HollyFrontier downgraded to Underweight from Equal Weight at Morgan Stanley
06/30/20 Cowen
HollyFrontier downgraded to Underperform at Cowen
06/30/20 Cowen
HollyFrontier downgraded to Underperform from Market Perform at Cowen
06/12/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Earnings
KVH Industries reports Q3 adj. cont. ops. EPS 6c, consensus (17c) » 07:06
10/29/20
10/29
07:06
10/29/20
07:06
KVHI

KVH Industries

$8.70 /

-0.3 (-3.33%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KVHI KVH Industries
$8.70 /

-0.3 (-3.33%)

KVHI KVH Industries
$8.70 /

-0.3 (-3.33%)

Earnings
Church & Dwight raises FY20 outlook » 07:06
10/29/20
10/29
07:06
10/29/20
07:06
CHD

Church & Dwight

$88.26 /

-3.925 (-4.26%)

CEO Farrell stated,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

08/03/20 Truist
Church & Dwight price target raised to $105 from $90 at Truist
08/03/20 RBC Capital
Church & Dwight price target raised to $90 from $65 at RBC Capital
08/03/20 Deutsche Bank
Church & Dwight price target raised to $89 from $78 at Deutsche Bank
07/24/20 Oppenheimer
Church & Dwight price target raised to $100 from $88 at Oppenheimer
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

Earnings
Magellan Health backs 2020 adjusted EPS view 63c-$1.10, consensus 91c » 07:05
10/29/20
10/29
07:05
10/29/20
07:05
MGLN

Magellan Health

$73.13 /

-1.72 (-2.30%)

Backs 2020 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

11/11/19 Jefferies
Magellan Health should trade higher on California win, says Jefferies
11/11/19 Stephens
Magellan Health price target raised to $67 after CA PBM win at Stephens
MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

Downgrade
Exact Sciences downgraded to Neutral from Buy at UBS » 07:05
10/29/20
10/29
07:05
10/29/20
07:05
EXAS

Exact Sciences

$127.65 /

-3.57 (-2.72%)

UBS analyst Dan Brennan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXAS Exact Sciences
$127.65 /

-3.57 (-2.72%)

EXAS Exact Sciences
$127.65 /

-3.57 (-2.72%)

10/28/20
Fly Intel: Top five analyst downgrades
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
10/28/20 SVB Leerink
Exact Sciences price target raised to $160 from $115 at SVB Leerink
10/28/20 Baird
Exact Sciences price target raised to $150 from $135 at Baird
EXAS Exact Sciences
$127.65 /

-3.57 (-2.72%)

EXAS Exact Sciences
$127.65 /

-3.57 (-2.72%)

EXAS Exact Sciences
$127.65 /

-3.57 (-2.72%)

Earnings
Church & Dwight sees Q4 EPS 50c-52c, consensus 55c » 07:05
10/29/20
10/29
07:05
10/29/20
07:05
CHD

Church & Dwight

$88.26 /

-3.925 (-4.26%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

08/03/20 Truist
Church & Dwight price target raised to $105 from $90 at Truist
08/03/20 RBC Capital
Church & Dwight price target raised to $90 from $65 at RBC Capital
08/03/20 Deutsche Bank
Church & Dwight price target raised to $89 from $78 at Deutsche Bank
07/24/20 Oppenheimer
Church & Dwight price target raised to $100 from $88 at Oppenheimer
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

Earnings
Comcast reports Q3 adj. EPS 65c, consensus 52c » 07:05
10/29/20
10/29
07:05
10/29/20
07:05
CMCSA

Comcast

$42.05 /

-1.39 (-3.20%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
CMCSK Comcast
$0.00 /

+ (+0.00%)

10/07/20 Benchmark
Benchmark would be 'aggressive buyer' of Comcast amid broader market weakness
09/22/20 Benchmark
Comcast price target raised to $60 from $54 at Benchmark
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
07/01/20
Fly Intel: Top five analyst upgrades
CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$42.05 /

-1.39 (-3.20%)

Earnings
Molson Coors says unable to provide updated detailed financial outlook » 07:04
10/29/20
10/29
07:04
10/29/20
07:04
TAP

Molson Coors

$32.95 /

-0.88 (-2.60%)

Molson Coors said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

07/15/20 Bryan Garnier
Molson Coors upgraded to Buy from Sell at Bryan Garnier
04/30/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/09/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/01/20 Goldman Sachs
Molson Coors resumed with a Sell at Goldman Sachs
TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

Hot Stocks
Eli Lilly: Data confirms long-term efficacy with Taltz in psoriasis, PA » 07:04
10/29/20
10/29
07:04
10/29/20
07:04
LLY

Eli Lilly

$131.30 /

-0.63 (-0.48%)

Eli Lilly and Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

10/27/20 Benchmark
Lilly stop may 'hint' at similar results for Regeneron cocktail, says Benchmark
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Eli Lilly initiated with a Buy at Truist
10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

Recommendations
Avantor price target raised to $27 from $23 at Baird » 07:04
10/29/20
10/29
07:04
10/29/20
07:04
AVTR

Avantor

$23.39 /

-1.04 (-4.26%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVTR Avantor
$23.39 /

-1.04 (-4.26%)

AVTR Avantor
$23.39 /

-1.04 (-4.26%)

10/28/20 Wells Fargo
Avantor price target raised to $28 from $23 at Wells Fargo
10/09/20 Jefferies
Avantor price target raised to $30 from $25 at Jefferies
09/14/20 Morgan Stanley
Avantor initiated with an Overweight at Morgan Stanley
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
AVTR Avantor
$23.39 /

-1.04 (-4.26%)

  • 20
    Aug
  • 21
    May
  • 08
    Jan
AVTR Avantor
$23.39 /

-1.04 (-4.26%)

Earnings
Church & Dwight reports Q3 adjusted EPS 70c, consensus 67c » 07:04
10/29/20
10/29
07:04
10/29/20
07:04
CHD

Church & Dwight

$88.26 /

-3.925 (-4.26%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

08/03/20 Truist
Church & Dwight price target raised to $105 from $90 at Truist
08/03/20 RBC Capital
Church & Dwight price target raised to $90 from $65 at RBC Capital
08/03/20 Deutsche Bank
Church & Dwight price target raised to $89 from $78 at Deutsche Bank
07/24/20 Oppenheimer
Church & Dwight price target raised to $100 from $88 at Oppenheimer
CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

CHD Church & Dwight
$88.26 /

-3.925 (-4.26%)

Recommendations
KLA Corp. price target raised to $205 from $195 at Deutsche Bank » 07:04
10/29/20
10/29
07:04
10/29/20
07:04
KLAC

KLA Corp.

$190.62 /

-8.01 (-4.03%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLAC KLA Corp.
$190.62 /

-8.01 (-4.03%)

KLAC KLA Corp.
$190.62 /

-8.01 (-4.03%)

09/25/20 Citi
KLA on top, Amkor at bottom of Citi's Semiconductor rankings
09/20/20 Stifel
Stifel gets more positive on Semi Cap Equipment, upgrades KLA to Buy
09/20/20 Stifel
KLA Corp. upgraded to Buy from Hold at Stifel
08/14/20 Stifel
KLA Corp, ACM likely beneficiaries after Applied Materials earnings, says Stifel
KLAC KLA Corp.
$190.62 /

-8.01 (-4.03%)

KLAC KLA Corp.
$190.62 /

-8.01 (-4.03%)

KLAC KLA Corp.
$190.62 /

-8.01 (-4.03%)

Hot Stocks
Evelo Biosciences announces upcoming key milestones » 07:03
10/29/20
10/29
07:03
10/29/20
07:03
EVLO

Evelo Biosciences

$4.55 /

-0.02 (-0.44%)

EDP1815: Data from Phase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

Earnings
Magellan Health reports Q3 EPS 8c, consensus (10c) » 07:03
10/29/20
10/29
07:03
10/29/20
07:03
MGLN

Magellan Health

$73.13 /

-1.72 (-2.30%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

11/11/19 Jefferies
Magellan Health should trade higher on California win, says Jefferies
11/11/19 Stephens
Magellan Health price target raised to $67 after CA PBM win at Stephens
MGLN Magellan Health
$73.13 /

-1.72 (-2.30%)

Earnings
Molson Coors reports Q3 EPS $1.62, consensus $1.02 » 07:03
10/29/20
10/29
07:03
10/29/20
07:03
TAP

Molson Coors

$32.95 /

-0.88 (-2.60%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

07/15/20 Bryan Garnier
Molson Coors upgraded to Buy from Sell at Bryan Garnier
04/30/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/09/20 Consumer Edge
Molson Coors downgraded to Equal Weight from Overweight at Consumer Edge
04/01/20 Goldman Sachs
Molson Coors resumed with a Sell at Goldman Sachs
TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

TAP Molson Coors
$32.95 /

-0.88 (-2.60%)

Recommendations
General Electric price target raised to $9 from $6.81 at Deutsche Bank » 07:03
10/29/20
10/29
07:03
10/29/20
07:03
GE

General Electric

$7.43 /

+0.33 (+4.65%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

10/13/20 Deutsche Bank
General Electric price target raised to $6.81 from $6.25 at Deutsche Bank
10/09/20 Goldman Sachs
Goldman sees 50% upside in General Electric, reinstates shares at Buy
09/17/20 JPMorgan
Those calling GE guidance 'inflection' misunderstand business, says JPMorgan
08/31/20 JPMorgan
JPMorgan's Tusa withdraws GE price target, sees fair value below $5
GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

Hot Stocks
Evelo expects cash, cash equivalents to fund operations into 3Q21 » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
EVLO

Evelo Biosciences

$4.55 /

-0.02 (-0.44%)

As of September 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

Upgrade
Best Buy upgraded to Hold from Sell at R5 Capital » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
BBY

Best Buy

$111.01 /

-2.435 (-2.15%)

R5 Capital analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

06:59 Today R5 Capital
Correction: Best Buy, not Bed Bath & Beyond upgraded at R5 Capital
10/28/20 Piper Sandler
Piper calls Best Buy a favorite idea after 'very favorable' checks
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

Earnings
Evelo Biosciences reports Q3 EPS (45c), consensus (50c) » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
EVLO

Evelo Biosciences

$4.55 /

-0.02 (-0.44%)

"We can reduce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

Recommendations
PPD price target raised to $38 from $33 at Deutsche Bank » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
PPD

PPD

$33.18 /

-0.83 (-2.44%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$33.18 /

-0.83 (-2.44%)

PPD PPD
$33.18 /

-0.83 (-2.44%)

10/12/20 Truist
PPD, Inc. initiated with a Buy at Truist
09/22/20 Mizuho
PPD, Inc. price target raised to $38 from $35 at Mizuho
09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
08/06/20 Mizuho
PPD, Inc. price target raised to $35 from $29 at Mizuho
PPD PPD
$33.18 /

-0.83 (-2.44%)

  • 17
    Sep
  • 06
    Feb
PPD PPD
$33.18 /

-0.83 (-2.44%)

Earnings
1-800-Flowers.com sees Q2 adjusted EPS growth 18%-23% y-o-y, consensus $1.31 » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
FLWS

1-800-Flowers.com

$25.23 /

-0.59 (-2.29%)

Sees Q2 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/25/20 DA Davidson
DA Davidson keeps 'priced to perfection' 1-800-Flowers.com at Underperform
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

Earnings
International Paper reports Q3 adjusted EPS 71c, consensus 48c » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
IP

International Paper

$42.97 /

-1.41 (-3.18%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IP International Paper
$42.97 /

-1.41 (-3.18%)

10/11/20 BMO Capital
International Paper upgraded to Outperform from Market Perform at BMO Capital
10/09/20
Fly Intel: Top five analyst upgrades
10/09/20 Wells Fargo
International Paper upgraded to Overweight from Equal Weight at Wells Fargo
10/09/20 Wells Fargo
International Paper upgraded to Overweight from Equal Weight at Wells Fargo
IP International Paper
$42.97 /

-1.41 (-3.18%)

IP International Paper
$42.97 /

-1.41 (-3.18%)

IP International Paper
$42.97 /

-1.41 (-3.18%)

Recommendations
Teladoc price target raised to $244 from $239 at Deutsche Bank » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
TDOC

Teladoc

$227.00 /

+4.42 (+1.99%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

10/28/20 Piper Sandler
Livongo Health downgraded to Neutral from Overweight at Piper Sandler
10/28/20 Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

Recommendations
Bed Bath & Beyond weakness a buying opportunity, says Baird » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
BBBY

Bed Bath & Beyond

$21.10 /

-2.91 (-12.12%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

06:59 Today R5 Capital
Correction: Best Buy, not Bed Bath & Beyond upgraded at R5 Capital
06:35 Today Morgan Stanley
Morgan Stanley ups Bed Bath & Beyond to Equal Weight, quadruples target to $24
06:32 Today Morgan Stanley
Bed Bath & Beyond upgraded to Equal Weight from Underweight at Morgan Stanley
06:05 Today Telsey Advisory
Bed Bath & Beyond upgraded to Outperform from Market Perform at Telsey Advisory
BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

Recommendations
CME Group price target lowered to $167 from $181 at Deutsche Bank » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
CME

CME Group

$149.56 /

-9.81 (-6.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

09/23/20 Atlantic Equities
CME Group upgraded to Overweight from Neutral at Atlantic Equities
09/11/20 Loop Capital
Loop Capital initiates exchanges, market-structure names w/ fintech focus
09/11/20 Loop Capital
CME Group initiated with a Sell at Loop Capital
07/30/20 Deutsche Bank
CME Group price target lowered to $178 from $196 at Deutsche Bank
CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

Earnings
A.O. Smith raises FY20 adj. EPS view to $1.95-$1.98 from $1.72-$1.86 » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
AOS

A.O. Smith

$51.26 /

-1.51 (-2.86%)

Consensus $1.87."We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

10/23/20 Citi
A.O. Smith initiated with a Neutral at Citi
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
09/17/20
Fly Intel: Top five analyst upgrades
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.